Cilostazol is a promising anti-pseudomonal virulence drug by disruption of quorum sensing [PDF]
Mohammed W. Al-Rabia +8 more
openalex +1 more source
Reduction of MMP-9 and MIF Levels is Associated with the Beneficial Effects of Cilostazol in the Patients with Silent Brain Infarcts [PDF]
Jin Ho Lee +9 more
openalex +1 more source
Cilostazol increases collateral remodeling and reduces the severity of ischemic stroke. [PDF]
Zhang H, Ding MC, Gong G, Faber JE.
europepmc +1 more source
E<b>F</b>fects of Y-6 S<b>U</b>blingual Tablets for Pa<b>T</b>ients with Ac<b>U</b>te Ischemic St<b>R</b>ok<b>E</b> (FUTURE): a phase II, randomised, double-blind, double-dummy, placebo-controlled, parallel trial. [PDF]
Wang Y +14 more
europepmc +1 more source
Effect of triple versus dual antiplatelet therapy in patients undergoing percutaneous intervention: systematic review and meta-analysis with GRADE system. [PDF]
Elhaddad IM +9 more
europepmc +1 more source
Antiplatelet treatment with cilostazol after stent implantation [PDF]
Yuji Yoshitomi +5 more
openalex +1 more source
Mexiletine prevents transient heart failure in a polymicrogyria child with an ATP1A3 variant: a case report. [PDF]
Aida M +4 more
europepmc +1 more source
Refractory Livedoid Vasculopathy Successfully Treated with Hyperbaric Oxygen Therapy and Tofacitinib. [PDF]
Mani S +5 more
europepmc +1 more source

